Literature DB >> 28848023

Prevalence of age-related macular degeneration in rural southern China: the Yangxi Eye Study.

Guangming Jin1, Xiaohu Ding1, Wei Xiao1, Xiao Xu2, Lanhua Wang1, Xiaotong Han1, Ou Xiao1, Ran Liu1, Wei Wang1, William Yan3, Lei An2, Jialiang Zhao4, Mingguang He1,3.   

Abstract

PURPOSE: To describe the prevalence of age-related macular degeneration (AMD) among older adults in rural southern mainland China.
METHODS: Eligible persons aged 50 years or over were identified by geographically defined cluster sampling from Yangxi County, Guangdong Province, China. Participants underwent a standardised interview and comprehensive eye examinations from August to November in 2014. Digital retinal photographs were graded for AMD lesions using the Clinical Classification of Age-Related Macular Degeneration developed by the Beckman Initiative for Macular Research Classification Committee. Age-standardised prevalence of AMD and AMD lesions was calculated using the 2010 world population data and compared with those of other populations.
RESULTS: Of 5825 subjects who participated (90.7% response rate), 4881 (83.8%) had fundus photographs gradable for AMD. Early, intermediate and late AMD were present in 2003 (41.0%), 879 (18.0%) and 42 (0.86%) participants. The age-standardised prevalence of early, intermediate and late AMD was 40.4% (95% CI 39.6% to 41.2%), 17.6% (95% CI 17.0% to 18.2%) and 0.79% (95% CI 0.65% to 0.95%), respectively. Total AMD was more prevalent in men than in women (62.8% vs 57.1%).
CONCLUSIONS: AMD is an important public health concern for rural southern China, and the prevalence of AMD was higher in men than in women. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Rural China; age-related macular degeneration; prevalence

Mesh:

Year:  2017        PMID: 28848023     DOI: 10.1136/bjophthalmol-2017-310368

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  iTRAQ-based proteomics analysis of aqueous humor in patients with dry age-related macular degeneration.

Authors:  Si-Chang Qu; Ding Xu; Ting-Ting Li; Jing-Fa Zhang; Fang Liu
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

2.  A self-adaptive deep learning method for automated eye laterality detection based on color fundus photography.

Authors:  Chi Liu; Xiaotong Han; Zhixi Li; Jason Ha; Guankai Peng; Wei Meng; Mingguang He
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

3.  Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.

Authors:  Ruyue Li; Ziwei Yang; Yue Zhang; Weiling Bai; Yifan Du; Runzhou Sun; Jianjun Tang; Ningli Wang; Hanruo Liu
Journal:  Lancet Reg Health West Pac       Date:  2022-03-26

4.  The frequency of early age-related macular degeneration and its relationship with dietary pattern in Hunan, China: a cross-sectional study.

Authors:  Yanhui Lin; Ting Peng; Ying Li; Yu Liu
Journal:  BMC Ophthalmol       Date:  2022-07-27       Impact factor: 2.086

5.  Incidence and Clinical Practice of Exudative Age-related Macular Degeneration: A Nationwide Population-Based Cohort Study.

Authors:  Ai Kido; Masahiro Miyake; Hiroshi Tamura; Shusuke Hiragi; Takeshi Kimura; Satomi Yoshida; Masato Takeuchi; Shosuke Ohtera; Ayako Takahashi; Sotaro Ooto; Koji Kawakami; Tomohiro Kuroda; Akitaka Tsujikawa
Journal:  Ophthalmol Sci       Date:  2022-03-01

6.  Subretinal Saline Protects the Neuroretina From Thermic Damage During Laser Induction of Experimental Choroidal Neovascularization in Pigs.

Authors:  Silja Hansen; Anne Louise Askou; Morten la Cour; Thomas J Corydon; Toke Bek
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

Review 7.  Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions.

Authors:  Thales Antonio Cabral de Guimaraes; Michalis Georgiou; James W B Bainbridge; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2020-04-08       Impact factor: 4.638

8.  Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study.

Authors:  Lei Gao; Yuan Tao; Min Liu; Linlin Li; Peng Zhang; Hong Wang; Linna Zhang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.